83602-157 NDC - LIDOCAINE PAIN RELIEF GEL-PATCH (LIDOCAINE)

Drug Information

  • Product NDC: 83602-157
  • Proprietary Name: Lidocaine Pain Relief Gel-Patch
  • Non Proprietary Name: Lidocaine
  • Active Ingredient(s): .04 g/g LIDOCAINE.04 g/g LIDOCAINE.04 g/g LIDOCAINE
  • Administration Route(s): TOPICAL
  • Dosage Form(s): PATCH
  • Pharmacy Class(es): Amide Local Anesthetic [EPC]; Amides [CS]; Antiarrhythmic [EPC]; Local Anesthesia [PE]

Labeler Information

Field Name Field Value
Labeler Name: Guangzhou Liuquanmiao Import & Export Trade Co., Ltd.
Product Type: HUMAN OTC DRUG
FDA Application Number: M017
Marketing Category: OTC MONOGRAPH DRUG
Start Marketing Date:10/27/2023

Package Information

No. Package Code Package Description Billing Unit
183602-157-0112 g in 1 BAG (83602-157-01)
283602-157-1212 PATCH in 1 BOX (83602-157-12) / 12 g in 1 PATCH
383602-157-1313 PATCH in 1 BOX (83602-157-13) / 12 g in 1 PATCH
483602-157-1414 PATCH in 1 BOX (83602-157-14) / 12 g in 1 PATCH
583602-157-1515 BAG in 1 BOX (83602-157-15) / 12 g in 1 BAG
683602-157-1616 PATCH in 1 BOX (83602-157-16) / 12 g in 1 PATCH
783602-157-1717 PATCH in 1 BOX (83602-157-17) / 12 g in 1 PATCH
883602-157-1818 PATCH in 1 BOX (83602-157-18) / 12 g in 1 PATCH
983602-157-1919 PATCH in 1 BOX (83602-157-19) / 12 g in 1 PATCH
1083602-157-2020 PATCH in 1 BOX (83602-157-20) / 12 g in 1 PATCH
1183602-157-2121 PATCH in 1 BOX (83602-157-21) / 12 g in 1 PATCH
1283602-157-2222 PATCH in 1 BOX (83602-157-22) / 12 g in 1 PATCH
1383602-157-2323 PATCH in 1 BOX (83602-157-23) / 12 g in 1 PATCH
1483602-157-2424 PATCH in 1 BOX (83602-157-24) / 12 g in 1 PATCH
1583602-157-2525 PATCH in 1 BOX (83602-157-25) / 12 g in 1 PATCH
1683602-157-2626 PATCH in 1 BOX (83602-157-26) / 12 g in 1 PATCH
1783602-157-2727 PATCH in 1 BOX (83602-157-27) / 12 g in 1 PATCH
1883602-157-2828 PATCH in 1 BOX (83602-157-28) / 12 g in 1 PATCH
1983602-157-2929 PATCH in 1 BOX (83602-157-29) / 12 g in 1 PATCH
2083602-157-3030 BAG in 1 BOX (83602-157-30) / 12 g in 1 BAG
2183602-157-3131 PATCH in 1 BOX (83602-157-31) / 12 g in 1 PATCH
2283602-157-3232 PATCH in 1 BOX (83602-157-32) / 12 g in 1 PATCH
2383602-157-3333 PATCH in 1 BOX (83602-157-33) / 12 g in 1 PATCH
2483602-157-3434 PATCH in 1 BOX (83602-157-34) / 12 g in 1 PATCH
2583602-157-3535 PATCH in 1 BOX (83602-157-35) / 12 g in 1 PATCH
2683602-157-3636 PATCH in 1 BOX (83602-157-36) / 12 g in 1 PATCH
2783602-157-3737 PATCH in 1 BOX (83602-157-37) / 12 g in 1 PATCH
2883602-157-3838 PATCH in 1 BOX (83602-157-38) / 12 g in 1 PATCH
2983602-157-3939 PATCH in 1 BOX (83602-157-39) / 12 g in 1 PATCH
3083602-157-4040 PATCH in 1 BOX (83602-157-40) / 12 g in 1 PATCH
3183602-157-4141 PATCH in 1 BOX (83602-157-41) / 12 g in 1 PATCH
3283602-157-4242 PATCH in 1 BOX (83602-157-42) / 12 g in 1 PATCH
3383602-157-4343 PATCH in 1 BOX (83602-157-43) / 12 g in 1 PATCH
3483602-157-4444 PATCH in 1 BOX (83602-157-44) / 12 g in 1 PATCH
3583602-157-4545 PATCH in 1 BOX (83602-157-45) / 12 g in 1 PATCH
3683602-157-4646 PATCH in 1 BOX (83602-157-46) / 12 g in 1 PATCH

NDC Record

Field Name Field Value Definition
PRODUCT NDC83602-157The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMELidocaine Pain Relief Gel-PatchThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMELidocaineThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMEPATCHThe translation of the dosage form Code submitted by the firm.
ROUTE NAMETOPICALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE10/14/2024This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEOTC MONOGRAPH DRUGProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
APPLICATION NUMBERM017This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
LABELER NAMEGuangzhou Liuquanmiao Import & Export Trade Co., Ltd.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMELIDOCAINEAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH.04 
ACTIVE INGRED UNITg/g 
PHARM CLASSESAmide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE] 
PRODUCT NDC83602-157The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMELidocaine Pain Relief Gel-PatchThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMELidocaineThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMEPATCHThe translation of the dosage form Code submitted by the firm.
ROUTE NAMETOPICALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE3/24/2025This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEOTC MONOGRAPH DRUGProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
APPLICATION NUMBERM017This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
LABELER NAMEGuangzhou Liuquanmiao Import & Export Trade Co., Ltd.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMELIDOCAINEAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH.04 
ACTIVE INGRED UNITg/g 
PHARM CLASSESAmide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE] 
PRODUCT NDC83602-157The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMELidocaine Pain Relief Gel-PatchThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMELidocaineThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMEPATCHThe translation of the dosage form Code submitted by the firm.
ROUTE NAMETOPICALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE10/27/2023This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEOTC MONOGRAPH DRUGProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
APPLICATION NUMBERM017This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
LABELER NAMEGuangzhou Liuquanmiao Import & Export Trade Co., Ltd.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMELIDOCAINEAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH.04 
ACTIVE INGRED UNITg/g 
PHARM CLASSESAmide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE] 

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 12/6/2025